Company Quick10K Filing
Quest Management
10-K 2019-10-31 Filed 2020-05-12
10-Q 2019-07-31 Filed 2020-04-23
10-Q 2019-04-30 Filed 2020-04-23
10-Q 2019-01-31 Filed 2020-04-23
10-K 2018-10-31 Filed 2020-03-27
10-Q 2018-07-31 Filed 2020-02-12
10-Q 2018-04-30 Filed 2018-06-19
10-Q 2018-01-31 Filed 2018-03-06
10-K 2017-10-31 Filed 2018-02-13
10-Q 2017-07-31 Filed 2017-09-14
10-Q 2017-04-30 Filed 2017-05-23
10-Q 2017-01-31 Filed 2017-03-17
10-K 2016-10-31 Filed 2017-02-14
10-Q 2016-07-31 Filed 2016-09-14
10-Q 2016-04-30 Filed 2016-06-01
10-Q 2016-01-31 Filed 2016-03-01
10-K 2015-10-31 Filed 2016-01-29
10-Q 2015-07-31 Filed 2015-09-17
10-Q 2015-04-30 Filed 2015-06-08
10-Q 2015-01-31 Filed 2015-03-18

Quest Management Financials

QUEST Metrics, Comps, Filings

Quarterly | Annual

Business

We are a development stage company that has generated $235,133 in revenues to date, and our accumulated profit (loss) as of October 31, 2017 is $(56,034). Our independent auditor has issued an audit opinion for our Company which includes a statement expressing substantial doubt as to our ability to continue as a going concern. The Company's office is located at 1 Kalnu iela, Malta, LV-4630 Latvia, which we purchased on October 31st, 2014 for $7,915. Our telephone number is (702) 907-8836.

We are in the early stages of developing our business, which is to develop marketing channels to distribute third-party fitness equipment to wholesale markets in the US.

We received the initial equity funding of $4,000 from our sole officer and director who purchased 4,000,000 shares of our common stock at $0.001 per share. In March 2015, the Company issued 1,000,000 shares of common stock to 30 independent persons pursuant to the Registration Statement on Form S-1 for total cash proceeds of $40,000.


Valuation ($)

Market Cap, Enterprise Value

Balance Sheet ($)

Assets, Equity

Income Statement ($ Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($ Quarterly)

Ops, Inv, Fin

Comps ($ TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Stemcell Holdings (STMM) 113% -1.0 26% 12,032,848,000 6,023,444,000 7,313,554,000 8,234,525,000 3,099,084,000 4,927,199,000 -5,115,749,000
FCCC (FCCC) 1.5 -61% 92,000,000 3,000,000 0 0 -56,000,000 -56,000,000 -82,002,000
Tapinator (TAPM) 0% 0.1 -99% 1,783,274,000 951,832,000 4,322,948,000 0 -1,761,567,000 -1,761,567,000 -260,211,000
Nogales Resources (NLRT) 0% 517,000 187,974,000 0 0 0 0 -519,000
Golden Growers Cooperative (GGRO) -0% 0% 26,919,000,000 2,171,000,000 42,425,000,000 -45,000,000 0 0 -3,508,002,000
Northern Power Systems (NPS) 22% 0.4 -27% 8,927,000,000 13,901,000,000 18,317,000,000 4,050,000,000 -2,379,000,000 -1,701,000,000 -670,002,000
Twin River Worldwide (TRWH) 0% 4.0 4% 1,070,918,000,000 808,153,000,000 393,158,000,000 0 41,775,000,000 112,100,000,000 449,559,999,000
Bio-En (BENH) 0.1 -643% 10,396,000 149,279,000 0 0 -66,818,000 -66,818,000 -4,687,000
Southwest Iowa Renewable Energy (SIRE) -1% -47.3 -1% 140,863,000,000 51,558,000,000 216,993,000,000 -1,931,000,000 -1,169,518,000 -536,518,000 25,395,999,000
Texas Republic Capital (TRCC) 0% 8.9 -5% 26,314,961,000 14,988,148,000 930,677,000 0 -1,274,149,000 -1,274,149,000 -11,327,584,000
Fannie Mae (FNM) 28.1 0% 3,494,436,000,000,000 3,484,094,000,000,000 0 0 13,025,000,000,000 119,732,000,000,000 3,361,547,999,999,000
CBA Florida (CBAI) 43.6 -1% 14,544,469,000 597,854,000 0 0 -210,911,000 -260,844,000 -11,367,563,000
Pacific Gold & Royalty (PCFG) -7.1 0 3,799,496,000 0 -2,545,000 -238,328,000 -45,194,000 319,839,000
BoxScore Brands (BOXS) 33% -8.3 -540% 312,912,000 7,564,280,000 338,295,000 110,302,000 -1,690,277,000 -701,925,000 5,793,309,000
Quest Management (QUEST) 27% -0.3 129% 12,526,000 6,028,000 45,177,000 12,318,000 16,132,000 16,164,000 -5,306,000
Zhen Ding Resources (RBTK) 0.1 48,309,900% 0 0 -483,099,000 -68,261,000 -6,097,000
Hines Global REIT (HGRI) 0% 1.7 19% 2,010,946,000,000 999,520,000,000 205,149,000,000 0 388,366,000,000 421,651,000,000 715,766,999,000
Wadena (WDN) 0% 0.0 -2,344% 11,999,000 696,137,000 87,000,000 0 -281,214,000 -278,021,000 -5,132,000
Galera Therapeutics (GRTX) 1.3 -17% 79,758,000,000 52,298,000,000 0 0 -13,351,000,000 -12,433,000,000 -15,719,002,000
Chase General (CSGN) 26% -0.5 -2% 1,563,342,000 1,016,098,000 2,493,194,000 657,636,000 -32,054,000 13,371,000 -6,929,000

Balance Sheet ($)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-30
Cash16,336,0008,899,0006,317,0002,504,000280,0001,008,0001,209,000301,000133,000499,0003,684,0001,640,0005,120,0005,304,000
Accounts Receivable
Inventory
PP&E7,915,0007,915,0007,915,0007,717,0007,668,0007,618,0007,569,0007,519,0007,915,0007,915,0007,915,0007,321,0007,272,0007,222,000
Assets24,251,00016,715,00014,083,00010,222,0007,948,0008,626,0008,778,0007,820,0007,602,0007,919,00011,054,0008,961,00012,392,00012,526,000
Accounts Payable5,000,0005,000,0005,000,0005,000,0005,000,0005,000,000000000
Long-Term Debt
Liabilities150,000150,0008,666,0009,066,0009,066,0009,066,0009,066,0009,066,0005,671,0005,671,0005,671,0005,995,0006,012,0006,028,000
Stockholders' Equity24,101,00016,565,0005,417,0001,156,000-1,118,000-440,000-288,000-1,246,0001,931,0002,248,0005,383,0002,966,0006,380,0006,498,000
Income Statement ($)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-30
Revenue31,274,00031,569,00030,006,000-6,802,0006,993,0007,865,00011,973,00016,629,00012,533,0008,967,0009,168,00013,341,00011,775,00010,893,000
Cost of Revenue18,907,00034,886,00024,018,0003,735,0006,872,0005,315,00010,630,00014,091,00012,629,0005,660,0005,983,00012,996,0006,840,0007,040,000
Gross Profit12,367,000-3,317,0005,988,000-10,537,000121,0002,550,0001,343,0002,538,000-96,0003,307,0003,185,000345,0004,935,0003,853,000
R&D14,846,000000000000000
SG&A97,000030,00048,769,0002,345,0001,822,0001,143,0003,446,00011,678,0002,941,0000-9,217,0001,456,0003,669,000
Tax00000000000000
Net Income11,604,000-47,536,000-11,148,000-3,861,000-2,274,000678,000151,000-957,000-11,823,000317,0003,135,0009,464,0003,414,000119,000
Cash Flow ($)2015-01-312015-04-302015-07-312015-10-312016-01-312016-04-302016-07-312016-10-312017-01-312017-04-302017-07-312017-10-312018-01-312018-04-30
Cash Operating11,604,000-47,437,000-6,098,000-4,010,000-2,274,000679,000151,000-957,000-3,346,00050,00049,000-10,612,0003,430,000135,000
Cash Investing-7,915,000008,113,00049,00050,00049,00050,00049,00050,000
Cash Financing100,00040,000,0003,516,0000000015,000,00000000